In addition, CCR7 has been demonstrated to inhibit apoptosis and stimulate proliferation by promoting G2/M phase progression through the ERK1/2 pathway in NSCLC [171]. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.